Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
A Method to Predict Comorbid Conditions Using Risk Factor Profile of Multiple Fluid Biomarkers
Priyanka Jadhav1, Vinothini Selvaraju1, Ramakrishnan Swaminathan1
1Biomedical Engineering, Department of Applied Mechanics, Indian Institute of Technology Madras, Chennai, India.
Abstract:
The co-occurrence of diabetes, hypertension, and cardiovascular diseases together can make clinical management and treatment more complex. Early detection of comorbid conditions can help in creating personalized treatment plans. Multiple fluid biomarkers can be used to enhance the diagnostic accuracy of identifying comorbidity. This study aims to distinguish non-comorbid and comorbid conditions using the risk factor profile of multiple fluid biomarkers, such as creatine phosphokinase, platelet count, serum creatinine, and ejection fraction. Area feature is computed by utilizing risk factor profile of the biomarkers, and a random forest classifier is used to distinguish the two conditions. The results indicate that the area of the radar plot is more significant for differentiating comorbid from non-comorbid conditions. RF classifier achieves the highest accuracy of 59.91% to differentiate the two conditions. Thus, multiple fluid biomarkers could be used to accurately detect the comorbid condition and improve the treatment plan individually.
Related Concept Videos
Composition of Body Fluids
Body Water Content and Fluid Compartments
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

